Cath lab safety has been a significant concern among interventional cardiologists and other clinicians for many years now. Procedures are associated with significant radiation exposure, and the heavy aprons worn inside these labs can lead to painful orthopedic injuries. 

More than 750,000 devices are included in the new Class II recall. At this time, however, no devices need to be returned to the manufacturer. 

There has been progress over the years, researchers noted, but there is still a lot of work to do. 

Cardiologists and vascular surgeons were previously told they could still use the device if necessary. Now, however, the message is that they should return the product to the manufacturer.

Back in June, CMS proposed significant updates to its current TAVR policies. Three leading healthcare societies have now joined forces to share their own perspective on the potential updates. 

Researchers pointed to the many benefits of cardiology conferences and emphasized that they do not think these events are directly leading to patient deaths. However, they wrote, "increased attention on staffing during meetings is warranted."

One of the platform's biggest benefits is the rich clinical information it provides to all members of the care team.

A surgeon in Michigan has performed the world’s first single-port robotic mitral valve repair.

High-volume hospitals are often associated with better TAVR outcomes. The team behind this new study wanted to see if a similar trend was seen with FTR rates as well. 

These "forward-thinking organizations" have all committed to participating in multiple data registries and quality improvement programs. Did your facility make the cut? 

Treating certain high-risk PCI patients with nicorandil before and after treatment can significantly reduce their risk of contrast-related injuries.